Ignite Creation Date:
2025-12-24 @ 7:42 PM
Ignite Modification Date:
2025-12-26 @ 4:59 AM
Study NCT ID:
NCT06022003
Status:
RECRUITING
Last Update Posted:
2025-03-24
First Post:
2023-08-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study Investigating the Efficacy and Safety of the Addition of Oral-azacitidine to Salvage Treatment by Gilteritinib in Subjects ≥18 Years of Age With Relapsed/Refractory FLT3-mutated Acute Myeloid Leukemia
Sponsor:
French Innovative Leukemia Organisation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-13
Start Date Type:
ACTUAL
Primary Completion Date:
2026-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-10
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-28
First Submit QC Date:
None
Study First Post Date:
2023-09-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-20
Last Update Post Date:
2025-03-24
Last Update Post Date Type:
ACTUAL